International Hepato-Pancreato-Biliary Association
Clinical Trial Registry
|Study Name||Institution/Hospital||Principal Investigator||
|A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma||
Memorial Sloan Kettering Cancer Center,
New York, USA.
|Dr. William Jarnagin.||Please see Clinical Trial Information here|
EUROPE, AFRICA AND MIDDLE EAST
|Study Name||Institution/Hospital||Principal Investigator||Further Information|
|NELMAS: phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best support care in patients after resection of neuroendocrine liver metastases||
Imperial College London
|Professor Andrea Frilling.||Please see Clinical Trial Information here|
If you would like to add details of an HPB Clinical Trial to the IHPBA registry please complete the form below.
All submissions will be reviewed by the IHPBA Research Committee before being added to the website.